Eli Lilly and Company vs. Teva Pharmaceuticals International GmbH et al.
Explore the PTAB proceeding IPR2022-00796 filed by Eli Lilly and Company on 2022-04-11. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2022-00796
Filing Date
2022-04-11
Accorded Filing Date
2022-04-11
Institution Decision Date
2022-10-14
Last Modified Date
2024-01-11
Proceeding Type
IPR
Termination Date
2023-10-11
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Eli Lilly and Company
Represented By
Feldstein, Market alPatent Owner / Respondent
Patent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
2 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (2)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 25351 | S Ludwig | +1 212-641-2320 |
| 30499 | Robert Sullivan Jr | +1 212-765-5070 |
| 31644 | P Musselman Jr | +1 214-292-4030 |
| 32983 | J Fasse | +1 617-542-5070 |
| 34609 | David Goren | +1 650-839-5070 |
| 34819 | Janis Fraser | +1 617-542-5070 |
| 35283 | Anita Meiklejohn | +1 617-542-5070 |
| 35322 | John Phillips | +1 858-678-5070 |
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 10,392,434 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2020022391 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 11,028,160 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 11,028,161 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2022009828 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 12,139,528 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2025026347 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2016623991 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2017625585 | US Continuation / Sibling | View Official Patent → |
Eli Lilly and Company v. Teva Pharmaceuticals International GmbH et al.
Eli Lilly and Company v. Teva Pharmaceuticals International GmbH et al.